Author

Jennifer Walker-Journey

6052 posts

Jennifer Walker-Journey is a professional writer whose 20-year career spans from newspapers and magazines to Ezines and business blogs. Her primary focus is corporate and business writing, though she relishes any opportunity to write features. In her limited free time, Jennifer strives to finish the novel she is writing. She lives in Birmingham with her husband, Rick, and their insatiably curious son, Truman.

Heart device linked to increased risk of heart attack, death

heartbeat

Patients with Absorb GT1 Bioresorbable Vascular Scaffold (BVS) are at greater risk of having a major cardiac event compared to patients treated with the metallic XIENCE drug-eluting stent, according to a Food and Drug Administration (FDA) Safety Communication. The BVS is used to open heart blood vessels (coronary arteries) blocked by scar tissue (plaque) in order to increase blood flow to the heart muscle. The BVS is implanted during an angioplasty procedure and gradually dissolves and is fully absorbed by the body over time. The FDA’s initial review of data from a pivitol clinical trial involving the BVS showed an ... Read More

Consumer Reports: 10 dietary supplements to avoid if you’re taking heart drugs

supplement - Wikipedia

People taking medication for high blood pressure, high cholesterol or other cardiovascular problems should avoid at least 10 dietary supplements, according to a new study published in the Journal of the American College of Cardiology. Researchers say the supplements can reduce the effectiveness of heart drugs or cause dangerous side effects. “Natural does not mean safe,” said Graziano Onder, MD, PhD, with the Universita Cattolica del Sacro Cuore in Rome. Many dietary supplements tout that they are “all natural” when in fact they contain synthetic ingredients or even hidden drug ingredients. Onder and his team set out to look at the ... Read More

Xarelto data featured at cardiology conference

xarelto

Johnson & Johnson, its subsidiary Janssen Pharmaceuticals, and Bayer presented late-breaking clinical trial data on the blockbuster new blood thinner Xarelto at the American College of Cardiology’s 66th Annual Scientific Session in Washington, D.C. March 17-19. The first study, called EINSTEIN CHOICE is the first Phase 3 research to evaluate the safety and efficacy in Xarelto versus aspirin for the extended secondary prevention of venous thromboembolism (VTE) – including both deep vein thrombosis (DVT) and pulmonary embolism (PE) – in individuals who have had an initial VTE and previously were treated for up to 12 months. Once a person experiences a ... Read More

Metformin helps reduce weight in children with autism treated with antipsychotics

risperdal

The commonly prescribed type 2 diabetes drug metformin is effective at reducing weight in overweight children and adolescents with autism spectrum disorder, and is especially true in children who take antipsychotic medication to treat their condition, according to a new study published in the Journal of the American Medical Association (JAMA). Children with autism are about twice as likely to be obese compared to adolescents without developmental disabilities, according to the Centers for Disease Control and Prevention (CDC). Two medications are approved to treat irritability with autism in children – risperidone (Risperdal) and aripiprazole (Abilfy). Both medications can cause significant ... Read More

Study finds increase in number of people prescribed opioids with benzos

World of Pain

The number of patients taking powerful opioid painkillers along with anti-anxiety drugs known as benzodiazepines increased significantly from 2001 to 2013, according to a study recently published in the British Medical Journal. The findings come just months after the Food and Drug Administration (FDA) announced that it was adding boxed warnings to the safety labels of both drugs as well as prescription cough medicines regarding serious side effects such as slowed or difficult breathing and deaths when the drugs are combined. Boxed warnings, also called black box warnings, are the strongest warning the FDA can give and are reserved for medications and medical ... Read More

Study: Testosterone replacement therapy not a ‘fountain of youth’

Low T

A year of testosterone replacement therapy did not improve memory but did increase the fatty plaque in coronary arteries, a condition that increases the risk for heart disease, according to a study newly published in the Journal of the American Medical Association and JAMA Internal Medicine. Testosterone replacement therapy, widely promoted by pharmaceutical companies for the treatment of so-called Low T, has become a $2 billion market. The prescription treatment is intended for men with hypogonadism, a condition in which the body does not produce enough of the male hormone. But because it has been heavily marketed and, thus, widely ... Read More

NJ company warned about selling adulterated, misbranded dietary supplements

dietary supplements - pills, probiotics

Joseph D’Arpa, owner of New Jersey-based Natural Generation Nutrition, was hit with a Food and Drug Administration (FDA) warning letter over labeling issues and the use of an herb or botanical ingredient that has not been established as safe for consumption. The product, NGN NATURAL generation nutrition ZXT2, listed for sale by the company as a dietary supplement, names the herb Acacia rigidula as an ingredient on its label. The ingredient, also called Vachellia, rigidula, chaparro prieto, and blackbrush, “was not marketed in the United States before October 15, 1994,” rendering it a “new dietary ingredient,” the warning letter states. ... Read More

Heart risks added to safety label of Children’s Motrin

childrens-motrin-ibuprofen

The labeling of over-the-counter Children’s Motrin has been updated to include a new warning regarding an increased risk of deadly heart attacks, heart failure and strokes, according to the Food and Drug Administration (FDA). Children’s Motrin, like Motrin for adults, contains ibuprofen, a painkiller from a family of drugs called non-steroidal anti-inflammatory drugs, or NSAIDs. Other drugs in this class include Advil (ibuprofen) and Aleve (naproxen). NSAIDs are sold both over-the-counter and by prescription. The new warning states: “Heart attack and stroke warning: NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. ... Read More

FDA panel says Opana ER too dangerous to stay on the market

fda-logo

A Food and Drug Administration (FDA) advisory panel charged with reviewing safety concerns with the powerful opioid Opana ER, determined that the risks outweighed the benefits, a decision that could lead to a market withdrawal. Opana ER is made by Endo Pharmaceuticals and is an extended release version of the painkiller oxymorphone. The company was granted approval from the FDA in 2006 to market an immediate-release oxymorphone called Opana IR. The patent expired in 2011, and Endo responded with an extended-release (ER) version that had been formulated with an “abuse deterrent” coating. The FDA told opioid manufacturers that it will ... Read More

More than 63K pounds of ground beef contaminated with ‘extraneous material’

ground beef

King’s Command Foods LLC is recalling approximately 63,252 pounds of ground beef products that may be contaminated with “extraneous material,” according to the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS). The problem was discovered when the company received several consumer complaints that metal objects were found in the beef products. To date, there are been no confirmed reports of injuries or adverse reactions due to the consumption of these products. Anyone with concerns about an injury or illness should contact their health care provider. This recall, which is an expansion of a previous recall announced March 9, ... Read More